Nikolaus Renz McFarland MD PhD
Movement Disorder, Neurodegenerative
Associate Professor of Neurology
Join to View Full Profile
3009 SW Williston RdGainesville, FL 32608
Phone+1 352-294-5400
Fax+1 352-627-4295
Dr. McFarland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nikolaus McFarland is a neurologist in Gainesville, FL and is affiliated with UF Health Shands Hospital. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice for over 15 years. He specializes in movement disorders and is experienced in advanced Parkinson disease care, atypical parkinson disorders (PSP, MSA, CBS, DLB), frontotemporal dementias, and Huntington disease. He is Director of the UF CurePSP Center of Care and the UF HDSA Center of Excellence, and is active in multiple clinical trials, education, and community outreach. He also directs the Fixel Biomarker laboratory, aimed at discovering novel markers of disease to help with diagnostics and tracking progression.
Education & Training
Massachusetts General Hospital2006 - 2008
University of Virginia Medical CenterResidency, Neurology, 2003 - 2006- University of Virginia Medical CenterInternship, Internal Medicine, 2002 - 2003
University of Rochester School of Medicine and DentistryClass of 2002
Certifications & Licensure
FL State Medical License 2010 - 2026
MA State Medical License 2006 - 2010
VA State Medical License 2002 - 2010
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments? Start of enrollment: 2012 May 01
- Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Start of enrollment: 2015 Oct 02
- Safety and Proof-of-Concept (POC) Study with AMT-130 in Adults with Early Manifest Huntington's Disease Start of enrollment: 2019 Sep 06
- Join now to see all
Publications & Presentations
PubMed
- Video analysis reveals early signs of Bradykinesia in REM sleep behavior disorder and Parkinson's disease.Diego L Guarín, Gabriela Acevedo, Carolina Calonge, Joshua K Wong, Nikolaus R McFarland
NPJ Parkinson's Disease. 2025-07-30 - Aerobic exercise-induced changes in fluid biomarkers in Parkinson's disease.Nijee S Luthra, Niyati Mehta, Miranda J Munoz, Giamila Fantuzzi, Guillaume Lamotte
NPJ Parkinson's Disease. 2025-07-01 - Language impairment is associated with faster progression in progressive supranuclear palsy-Richardson syndrome.Indira Garcia-Cordero, Juan Camilo Vargas-Gonzalez, Mohsen Hadian, Ece Bayram, Federico Rodriguez-Porcel
Alzheimer's & Dementia. 2025-07-01
Press Mentions
Fixel Leaders Shape the Future of Parkinson’s and Movement Disorders EducationAugust 7th, 2025- How UF Fixel Institute Supports the Future of Huntington’s Disease CareMay 20th, 2025
- Nikolaus McFarland, MD, PhDDecember 9th, 2024
- Join now to see all
Professional Memberships
- Member
- American Neurological Association - AANMember
- Society for NeuroscienceMember
- Movement Disorders SocietyMember
- Member
- Sigma Xi Research SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
